Filing Details

Accession Number:
0001535610-18-000069
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-16 10:28:48
Reporting Period:
2018-03-14
Accepted Time:
2018-03-16 10:28:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1362959 Rosetta Genomics Ltd. ROSG Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1535610 Sabby Management, Llc 10 Mountainview Road
Suite 205
Upper Saddle River NJ 07458
No No Yes No
1561018 Sabby Healthcare Master Fund, Ltd. C/O Sabby Management, Llc
10 Mountainview Road, Suite 205
Upper Saddle River NJ 07458
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Adr Shares (Each One Equal To 2 Ordinary Shares) Acquisiton 2018-03-14 800 $0.42 751,349 No 4 P Indirect See Footnotes
Adr Shares (Each One Equal To 2 Ordinary Shares) Acquisiton 2018-03-14 4,271 $0.42 755,620 No 4 P Indirect See Footnotes
Adr Shares (Each One Equal To 2 Ordinary Shares) Acquisiton 2018-03-14 200 $0.42 755,820 No 4 P Indirect See Footnotes
Adr Shares (Each One Equal To 2 Ordinary Shares) Acquisiton 2018-03-14 17,900 $0.42 773,720 No 4 P Indirect See Footnotes
Adr Shares (Each One Equal To 2 Ordinary Shares) Acquisiton 2018-03-14 50,020 $0.42 823,740 No 4 P Indirect See Footnotes
Adr Shares (Each One Equal To 2 Ordinary Shares) Acquisiton 2018-03-15 15,025 $0.42 838,765 No 4 P Indirect See Footnotes
Adr Shares (Each One Equal To 2 Ordinary Shares) Acquisiton 2018-03-15 34 $0.42 838,799 No 4 P Indirect See Footnotes
Adr Shares (Each One Equal To 2 Ordinary Shares) Acquisiton 2018-03-15 3,566 $0.42 842,365 No 4 P Indirect See Footnotes
Adr Shares (Each One Equal To 2 Ordinary Shares) Acquisiton 2018-03-15 13,545 $0.42 855,910 No 4 P Indirect See Footnotes
Adr Shares (Each One Equal To 2 Ordinary Shares) Acquisiton 2018-03-15 14,400 $0.42 870,310 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
Footnotes
  1. This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is manager of Advisor.
  2. The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise.